Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington University School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014268
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington University School of Medicine (WUSTL), a subsidiary of University of Washington is a medical university that offers patient care, research, education services and neurology clinical trials. The university provides patient care services such as clinical, find a doctor, referring physicians and others. Its research program comprise post doctoral research opportunities, research labs, knight ADRC, hope center, MS center, infantile spasms, regional, synaptic, and others. The university conducts neurology clinical trials such as headaches, multiple sclerosis and stroke, brain, spinal cord and nervous system, behavior and performance unit, aging, and sleep disorders, among others. It operates through four campus located in St. Louis, the US. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University School of Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 10
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12
Cerveau Technologies Enters into Agreement with Washington University School of Medicine 13
LEO Pharma Enters into Agreement with Washington University School of Medicine 14
Licensing Agreements 15
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 15
Washington University School of Medicine – Key Competitors 16
Washington University School of Medicine – Key Employees 17
Washington University School of Medicine – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Nov 06, 2017: $6 million supports leukemia research 19
Nov 02, 2017: In autism, too many brain connections may be at root of condition 21
Oct 18, 2017: New gene-altering treatment offered for certain blood cancers 23
Sep 05, 2017: Zika virus shrinks brain tumours in lab tests 25
Sep 05, 2017: Zika virus selectively infects and kills glioblastoma cells in mice 26
Jul 13, 2017: Experimental Zika Virus Vaccines Restrict In Utero Virus Transmission in Mice 27
Jun 14, 2017: UTI treatment reduces E. coli, may offer alternative to antibiotics 28
Jun 07, 2017: Nation’s Largest Suicide Prevention Organization Awards $1Million Research Grant to Researcher in St. Louis 30
Apr 27, 2017: Scientists at Shriners Hospitals for Children re-wire cells to produce arthritis vaccine 31
Apr 19, 2017: Antibody helps detect protein implicated in Alzheimer’s, other diseases 32
Dec 19, 2016: Landmark Alzheimer’s prevention trial to evaluate third drug 34
Oct 26, 2016: Study Questions Benefits of Long-Term Home Oxygen Therapy for COPD Patients with Moderately Low Blood Oxygen Levels 36
Oct 18, 2016: Gates Foundation Awards $1.1 Million Grant for MediBeacon Collaboration with Washington University 38
Sep 23, 2016: Researchers Take a New Step Towards Non-Antibiotic Bladder Infection Therapies 39
Sep 21, 2016: New immunotherapy for leukemia shows promise in small clinical trial 41
Jul 19, 2016: Potential new target identified for treating itch 43
Jul 04, 2016: Immune-based therapy in mice shows promise against pancreatic cancer 44
May 10, 2016: Stem cells from diabetic patients coaxed to become insulin-secreting cells 45
Feb 11, 2016: Venter Institute, International Team of Researchers Publish Paper Outlining Key Genes in Toxoplasma gondii Strains that Contribute to Virulence 46
Feb 03, 2016: Receptors inside nerve cells may be a key to controlling pain 47
Product News 48
Jul 05, 2016: Potential drug target identified for deadly brain cancer 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Washington University School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Washington University School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Washington University School of Medicine, Deals By Therapy Area, 2011 to YTD 2017 9
Washington University School of Medicine, Medical Devices Deals, 2011 to YTD 2017 10
Washington University School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine 12
Cerveau Technologies Enters into Agreement with Washington University School of Medicine 13
LEO Pharma Enters into Agreement with Washington University School of Medicine 14
Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine 15
Washington University School of Medicine, Key Competitors 16
Washington University School of Medicine, Key Employees 17
Washington University School of Medicine, Subsidiaries 18

★海外企業調査レポート[Washington University School of Medicine-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …
  • Saniona AB (SANION):企業の財務・戦略的SWOT分析
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • Genmedica Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company’s expertise spans provides development of specific, dual-action, small molecule inhibitors that targets …
  • Aegerion Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aegerion Pharmaceuticals Inc (Aegerion) is a pharmaceutical company that develops therapies for patients with debilitating often fatal and rare diseases. The company provides therapeutics to treat severe inherited lipid disorders. Its therapeutic focus comprise homozygous familial hyperchole …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Gentag Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to diagnostics and personal health. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, dia …
  • WuXi NextCODE Genomics:製薬・医療:M&Aディール及び事業提携情報
    Summary WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database arch …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Shinsegae Inc (004170):企業の財務・戦略的SWOT分析
    Shinsegae Inc (004170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AGC Inc (5201):企業の財務・戦略的SWOT分析
    AGC Inc (5201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Northfork Electric Cooperative, Inc.:発電所・企業SWOT分析
    Northfork Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Capita plc:企業の戦略・SWOT・財務情報
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • New Enterprise Associates Inc:企業のM&A・事業提携・投資動向
    New Enterprise Associates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Enterprise Associates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Total SA (FP):電力:M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …
  • KAZ Minerals PLC:企業のM&A・事業提携・投資動向
    KAZ Minerals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KAZ Minerals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Sotera Health LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • 23andMe Inc-製薬・医療分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆